NEWS DETAIL

CodeBreaK 101 auf der ASCO 2025: Sotorasib-Triplett im KRAS CRC – Oncodaily

CodeBreaK 101 auf der ASCO 2025: Sotorasib-Triple-Therapie für KRAS-positives kolorektales Karzinom (Oncodaily)

Medizinische Informationen July 2, 2026

Vollstaendiger Artikelinhalt

ASCO 2025: CodeBreaK 101 shows sotorasib triplet therapy offers durable responses in KRAS G12C-mutant metastatic colorectal cancer. , ASCO 2025 Annual Meeting, CodeBreaK 101 trial, colorectal cancer, KRASG12C

Produits lies a cet article

Ces produits ont ete automatiquement associes au titre, au resume et au contenu de l article.

Questions frequentes

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Sotorasib – Acheter en ligne SOTOLDX Sotorasib 120 mg.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.